WA
ALAB icon

Winter & Associates’s Astera Labs ALAB Stock Holding History

Winter & Associates’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Buy
+800
New +$212K 0.29% 52

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Winter & Associates's ALAB Position: Q2 2026 in Review

Winter & Associates opened a new position in Astera Labs (ALAB) in Q2 2026: 800 shares worth $386K. The stake represents 0.29% of the portfolio and ranks #52 among its holdings.

988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Winter & Associates held 800 shares of Astera Labs worth $386K as of Q2 2026.
  • Astera Labs was a new Winter & Associates position in Q2 2026.
  • Astera Labs made up 0.29% of Winter & Associates's portfolio in Q2 2026, its #52 holding.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Winter & Associates's 13F filing for Q2 2026, filed 9 Jul 2026.